Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Ptc Therapeutics (PTCT) Interest & Investment Income (2016 - 2025)

Ptc Therapeutics (PTCT) has 14 years of Interest & Investment Income data on record, last reported at -$55.2 million in Q4 2025.

  • For Q4 2025, Interest & Investment Income fell 34.41% year-over-year to -$55.2 million; the TTM value through Dec 2025 reached -$171.9 million, down 2.97%, while the annual FY2025 figure was -$152.2 million, 8.84% up from the prior year.
  • Interest & Investment Income reached -$55.2 million in Q4 2025 per PTCT's latest filing, down from -$34.1 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at -$19.2 million in Q1 2021 and bottomed at -$55.2 million in Q4 2025.
  • Average Interest & Investment Income over 5 years is -$31.2 million, with a median of -$27.7 million recorded in 2023.
  • Peak YoY movement for Interest & Investment Income: plummeted 319.39% in 2021, then rose 16.51% in 2025.
  • A 5-year view of Interest & Investment Income shows it stood at -$22.5 million in 2021, then dropped by 8.88% to -$24.5 million in 2022, then crashed by 80.71% to -$44.3 million in 2023, then increased by 7.26% to -$41.1 million in 2024, then plummeted by 34.41% to -$55.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Interest & Investment Income were -$55.2 million in Q4 2025, -$34.1 million in Q1 2025, and -$41.1 million in Q4 2024.